Toggle-SELEX is a sophisticated and powerful variant of the traditional SELEX process for aptamer development, specifically designed to generate aptamers that recognize multiple, closely related targets or a specific epitope common across different species/conditions. Let's break down what an Aptamer Screening Service using Toggle-SELEX entails, its applications, and what you should consider when selecting a service provider. What is Toggle-SELEX? The core idea of Toggle-SELEX is to "toggle" or alternate the selection pressure between two (or more) related target molecules during the SELEX rounds. Traditional SELEX: Uses a single target to evolve aptamers with high affinity for that specific target. It often negatively selects against related molecules (counter-selection) to ensure specificity. Toggle-SELEX: Actively uses two positive selection targets in an alternating pattern. For example: Round 1: Select against Target A (e.g., human protein). Round 2: Select against Target B (e.g., mouse ortholog of the same protein). Round 3: Back to Target A, and so on. Counter-selection against unrelated structures is still used to maintain general specificity. This process enriches for nucleic acid sequences that bind to a conserved structural epitope present on both targets, while sequences that bind to unique epitopes on only one target are filtered out. Key Applications of Toggle-SELEX This method is invaluable when you need cross-reactive or broad-spectrum recognition: Cross-Species Reactive Aptamers: Develop aptamers for preclinical research. For example, an…
Core Concept The central idea is "Target-based Drug Discovery." Instead of screening compounds on whole cells or organisms (phenotypic screening), you start with a specific protein (e.g., a kinase, receptor, ion channel) implicated in a disease. Services then help you understand that target and find molecules that modulate it. Categories of Protein Target Services These services typically follow the drug discovery pipeline: 1. Target Identification & Validation Bioinformatics & Omics Analysis: Mining genomic, proteomic, and clinical data to identify novel disease-associated targets. Genetic Validation: CRISPR/Cas9 gene editing (knock-out/knock-in), siRNA/shRNA knockdown to confirm the target's role in disease pathways. Functional Validation: Cell-based assays to see if modulating the target affects disease-relevant phenotypes. 2. Protein Expression & Purification Recombinant Protein Production: Cloning, expressing (in E. coli, insect, or mammalian cells), and purifying milligram to gram quantities of the target protein. This is essential for structural studies and biochemical assays. Membrane Protein Expertise: Specialized services for difficult-to-express targets like GPCRs and ion channels. Tagging & Labeling: Adding tags (His, GST, FLAG) for purification or fluorescent/isotopic labels for assays. 3. Structural Biology & Biophysics X-ray Crystallography: Determining high-resolution 3D structures of protein-ligand complexes. Cryo-Electron Microscopy (Cryo-EM): For large complexes or membrane proteins unsuitable for crystallography. Nuclear Magnetic Resonance (NMR) Spectroscopy: For studying dynamics and ligand binding in solution. Surface…
What are Aptamers? Aptamers are short, single-stranded DNA or RNA oligonucleotides (typically 20-80 nucleotides) that fold into specific three-dimensional shapes, enabling them to bind to target molecules with high affinity and specificity. They are often called "chemical antibodies." The process of creating them is called SELEX (Systematic Evolution of Ligands by EXponential enrichment), which iteratively selects aptamers from vast random-sequence libraries against a desired target (e.g., a protein, small molecule, or even a whole cell). Key Advantages of Aptamers as Therapeutics Compared to traditional protein-based biologics like antibodies, aptamers offer several compelling benefits: High Specificity & Affinity: Can distinguish between closely related targets (e.g., different protein isoforms). Small Size: Typically 8-25 kDa, much smaller than antibodies (~150 kDa). This can improve tissue penetration. Full Chemical Synthesis: Produced in vitro via chemical synthesis, eliminating batch-to-batch variability and the need for biological systems (cells or animals). This makes manufacturing scalable and consistent. Low Immunogenicity: Being nucleic acids, they are generally less likely to trigger immune reactions than foreign proteins. Excellent Stability: DNA aptamers, in particular, are thermally stable and can be stored easily. Stability in biological fluids can be engineered. Ease of Modification: Can be chemically modified to enhance stability (e.g., resist nucleases), prolong half-life (e.g., PEGylation), or add functional groups…
